ACMG recommends 22Q screening, Natera runs micro deletion, says Piper Sandler

Piper Sandler analyst David Westenberg reiterates an Overweight rating on Natera shares after the ACMG released guidelines recommending 22Q screening, likely a precursor to ACOG guidelines. The analyst tells investors in a research note that Natera is already running micro deletion, so this would be incremental revenue with zero incremental cost.